Tevosol Transplant Technologies

Challenge

The organ transplant space is an area in need of new possibilities. On average, surgeons perform just 35,000 organ transplants a year, yet the waiting list reaches beyond 120,000 people. The root of the problem isn’t donation, but rather utilization. Fewer than 25% of donated lungs and hearts are deemed suitable for transplantation due to the limiting factors of cold storage organ preservation.

Tevosol, Inc. is a medical device company developing a first-of-its-kind portable warm perfusion machine. It will allow surgeons to resuscitate, transport, and evaluate more donor organs to address the organ shortage. Currently in their series A phase with numerous prototypes in use, Tevosol approached my studio to help them establish their brand, share their story, and help them strengthen their industry partnerships.

Though their technology was revolutionary, Tevosol understood that more than innovative scientific knowhow was required in order to pursue and secure larger funding possibilities.

Solution

I worked with their leadership team to understand their strategy and establish their go-to-market approach. Together, we identified three areas to address immediately to help bolster their efforts: advance their brand identity to elevate their image, define a visual language to articulate their story, and refine the expression of the company and its mission through a website.

By addressing these communication needs, we ensured that Tevosol actively engaged investors who truly understood and appreciated their value. Internally, it inspired confidence in the leadership team and set the direction of the company. And overall, it elevated the perceptions and visibility of Tevosol and their mission.

My role: Account Services, Strategy, Creative Direction, Design